Kate Samuelson, TIME Friday, November 03, 2017
A stock photo of Starbucks.
Credit: Richard Bake—In Pictures via Getty Images
A stock photo of Starbucks.
COMMENTS
One person died and two others were injured in a shooting at a Starbucks in Uptown Chicago Thursday evening.
The victim was identified as father-of-two Sauvignon Watkins, 28, and one of the people left injured was a 12-year-old boy who suffered a gunshot wound to the groin, the Chicago Tribune reports. Police believe the shooting occurred following a drug deal involving the shooter and Watkins. The shooter is still at large.
President Donald Trump at a joint statement with Moon Jae-in, South Korea's president in Washington, D.C., on June 30, 2017.
Everything you need to know about President Trump’s grueling Asia tour
In this handout photo provided by the St. Charles County Department of Corrections, Sayfullo Saipov poses for a booking photo after a previous arrest in Missouri.
The Islamic State says the New York attacker is a 'Soldier of the Caliphate'
A spokesperson for Starbucks said it was “saddened to learn of the passing of a young man and the injury of two others as a result of gun violence at our store,” adding that the store would be closed Friday. “We will continue to support law enforcement in their investigation,” the coffee chain’s statement concluded.
A man was killed and two others, including a 12-year-old boy, were injured in a shooting in a Chicago Starbucks:
— CBS News (@CBSNews) November 3, 2017
On Nov. 1, the Associated Press reported that the number of homicides in Chicago in October 2017 was significantly lower than during October 2016. The city, the third-largest in the U.S., had seen 2,445 shooting incidents by that point of the year compared to 3,000 by the same time last year.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM